drugset / Trial / NCT07279727

Ultrasound-Guided Infraclvicular Block Using Dexmedetomidine Versus Nalbuphine as Adjuvants to Bupivacaine in Upper Limb Orthopedic Surgery

NCT07279727

Phase 1 Not yet recruiting 66 enrolled Assiut University
RandomizedParallel-groupTriple-blindDiagnostic

Summary

this study is designed to evaluate and compare the efficacy of dexmedetomidine and nalbuphine as adjuvants to 0.5% bupivacaine in ultrasound-guided infraclavicular brachial plexus block for patients undergoing elective upper limb orthopedic surgeries on the duration of analgesia.

Timeline

Start
2026-01-01
Primary completion
2026-12-31
Completion
2027-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 75 ug Other
Comparator Nalbuphine Small molecule 10 mg Other

Indications

No indication recorded.